These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9608250)

  • 41. Drug concentrations in axillary lymph nodes after lymphatic chemotherapy on patients with breast cancer.
    Chen J; Wang L; Yao Q; Ling R; Li K; Wang H
    Breast Cancer Res; 2004; 6(4):R474-7. PubMed ID: 15217515
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Postoperative loco-regional radiation therapy for breast cancer patients with four or more involved lymph nodes or extracapsular extension.
    Evron E; Barzily L; Rakowsky E; Ben-Baruch N; Sulkes J; Rizel S; Fenig E
    Isr Med Assoc J; 2005 Jul; 7(7):439-42. PubMed ID: 16011059
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy.
    Harris EE; Hwang WT; Seyednejad F; Solin LJ
    Cancer; 2003 Nov; 98(10):2144-51. PubMed ID: 14601083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Stage adjusted therapy of malignancies and breast cancers].
    Frobenius W; Tulusan AH; Lang N
    Geburtshilfe Frauenheilkd; 1994 Apr; 54(4):M51-6. PubMed ID: 8013849
    [No Abstract]   [Full Text] [Related]  

  • 46. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
    Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Early-stage breast cancer - strategies for adjuvant systemic therapy].
    Görner M; Just M; Gerull S
    Handchir Mikrochir Plast Chir; 2008 Aug; 40(4):230-8. PubMed ID: 18716990
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
    Yu H; Levesque MA; Clark GM; Diamandis EP
    Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The natural history of breast carcinoma in the elderly: implications for screening and treatment.
    Singh R; Hellman S; Heimann R
    Cancer; 2004 May; 100(9):1807-13. PubMed ID: 15112260
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic strategies for the management of carcinoma of the breast.
    Bland KI
    R I Med; 1995 Sep; 78(9):234-5. PubMed ID: 7579715
    [No Abstract]   [Full Text] [Related]  

  • 51. Comorbidity risk parameters associated with advanced breast cancer and systemic disease. Management of nonbreast disease.
    Graves TA; Bland KI
    Surg Oncol Clin N Am; 1995 Oct; 4(4):633-56. PubMed ID: 8535902
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Breast cancer: diagnosis and treatment.
    Palmer GA
    Nurse Pract Forum; 1993 Jun; 4(2):100-4. PubMed ID: 8513260
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Ulcerative breast neoplasm].
    Popovici A; Munţiu M; Mureşanu H; Martin S; Pănescu V
    Chirurgia (Bucur); 1994; 43(1):18-31. PubMed ID: 7521236
    [No Abstract]   [Full Text] [Related]  

  • 54. Treatment options for the patient with breast cancer.
    Waltman N
    Plast Surg Nurs; 1994; 14(1):15-23. PubMed ID: 7800757
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Adjuvant and neoadjuvant systemic therapy of breast carcinoma].
    Schmid P; Possinger K
    Internist (Berl); 2002 Mar; 43(3):341-4, 347-53. PubMed ID: 11963719
    [No Abstract]   [Full Text] [Related]  

  • 56. [Palliative hormone therapy of advanced breast cancer].
    Schröder W
    Gynakologe; 1993 Apr; 26(2):131-6. PubMed ID: 7685310
    [No Abstract]   [Full Text] [Related]  

  • 57. Locally advanced breast cancer.
    Swain SM
    Curr Opin Oncol; 1989 Dec; 1(2):318-23. PubMed ID: 2489974
    [No Abstract]   [Full Text] [Related]  

  • 58. Advances in the management of carcinoma of the breast.
    Forrest AP
    Surg Gynecol Obstet; 1986 Jul; 163(1):89-100. PubMed ID: 3523802
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Therapeutic indications in breast cancer].
    Lefranc JP
    Soins Gynecol Obstet Pueric; 1981 May; (4):11-3. PubMed ID: 6910909
    [No Abstract]   [Full Text] [Related]  

  • 60. [Directives for treatment of advanced breast cancer].
    Gundersen S
    Tidsskr Nor Laegeforen; 1984 Mar; 104(9):638-41. PubMed ID: 6203184
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.